Susanna Naggie, MD

Associate Professor of Medicine
Vice Dean for Clinical Research
Member in the Duke Clinical Research Institute
Campus mail 200 Morris Street, 6th Floor - 6410, Durham, NC 27701
Phone (919) 684-2584
Email address susanna.naggie@duke.edu

Dr. Susanna Naggie completed her medical education at Johns Hopkins School of Medicine and her internal medicine training at Duke University Medical Center (DUMC), where she also served as a Chief Resident in Internal Medicine.  She completed her Infectious Diseases (ID) fellowship training at Duke and then joined the faculty in the Division of ID. She is an Associate Professor of Medicine with Tenure and currently holds joint appointments at the Duke Clinical Research Institute (DCRI, Director of ID Research), and at the Durham Veterans Affairs Medical Center (DVAMC). Dr. Naggie has dedicated her academic career to the care of patients with HIV and viral hepatitis, with a research program focused on understanding the mechanisms of accelerated liver fibrogenesis in this population and the extrahepatic health outcomes attributed to HCV in persons with HIV infection. In addition to her investigator-initiated research program, Dr. Naggie is also involved in multiple clinical trials and clinical registries with a particular focus on HIV and liver disease. She is the prior co-Chair of the AASLD/IDSA HCV Guidance Committee and is currently Chair of the AIDS Clinical Trials Group Viral Hepatitis Transformative Science Group Committee and a member of the DHHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV and the CDC/NIH/IDSA-HIVMA Opportunistic Infections Guideline Committee. For the past two years Dr. Naggie has served as the Medical Director of the Duke Department of Medicine Clinical Research Unit.

Education and Training

  • Fellow in Infectious Diseases, Medicine, Duke University, 2007 - 2009
  • Chief Medical Resident - VAMC, Medicine, Duke University, 2006 - 2007
  • Medical Resident, Medicine, Duke University, 2002 - 2005
  • M.D., Johns Hopkins University, 2002

Publications

Lee, Tzu-Hao, Austin Chan, William Bryan, Lawrence Park, Mohamed Hashem, Mary Townsend, Cynthia Moylan, Rachel Britt, Steve Choi, and Susanna Naggie. “Proton pump inhibitor usage reduces sustained viral response rates for veterans with HIV/HCV coinfection on ledipasvir/sofosbuvir: a real-world study from a multicentre VA cohort.” J Viral Hepat, December 30, 2020. https://doi.org/10.1111/jvh.13462.

PMID
33378562
Full Text

Naggie, Susanna, and David Wyles. “Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination.” J Infect Dis 222, no. Supplement_9 (November 27, 2020): S741–44. https://doi.org/10.1093/infdis/jiaa425.

PMID
33245351
Full Text

Naggie, Susanna, Sam Lusk, J Will Thompson, Meredith Mock, Cynthia Moylan, Joseph E. Lucas, Laura Dubois, Lisa St John-Williams, M Arthur Moseley, and Keyur Patel. “Metabolomic Signature as a Predictor of Liver Disease Events in Patients With HIV/HCV Coinfection.” J Infect Dis 222, no. 12 (November 13, 2020): 2012–20. https://doi.org/10.1093/infdis/jiaa316.

PMID
32502252
Full Text

McKnight, Ashley H., Mary L. Townsend, Mohamed G. Hashem, Susanna Naggie, Lawrence P. Park, and Rachel B. Britt. “Standard Versus Extended Duration Direct-Acting Antiviral Therapy in Hepatitis C Patients With Slow Response to Treatment.” Ann Pharmacother 54, no. 11 (November 2020): 1057–64. https://doi.org/10.1177/1060028020921166.

PMID
32406244
Full Text

Okeke, Nwora Lance, Katherine R. Schafer, Eric G. Meissner, Jan Ostermann, Ansal D. Shah, Brian Ostasiewski, Evan Phelps, et al. “Cardiovascular Disease Risk Management in Persons With HIV: Does Clinician Specialty Matter?” Open Forum Infect Dis 7, no. 9 (September 2020): ofaa361. https://doi.org/10.1093/ofid/ofaa361.

PMID
32995348
Full Text

Moorman, Anne C., Marie A. de Perio, Ronald Goldschmidt, Carolyn Chu, David Kuhar, David K. Henderson, Susanna Naggie, et al. “Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus - CDC Guidance, United States, 2020.” Mmwr Recomm Rep 69, no. 6 (July 24, 2020): 1–8. https://doi.org/10.15585/mmwr.rr6906a1.

PMID
32701942
Full Text

Fuchs, Michael, Alexander Monto, Norbert Bräu, Mariem Charafeddine, Warren Schmidt, Michael Kozal, Susanna Naggie, et al. “Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders.” J Med Virol, December 12, 2019. https://doi.org/10.1002/jmv.25655.

PMID
31829433
Full Text

Morrison, Margaret, Heather Y. Hughes, Susanna Naggie, and Wing-Kin Syn. “Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?” Dig Dis Sci 64, no. 12 (December 2019): 3394–3401. https://doi.org/10.1007/s10620-019-05861-7.

PMID
31643035
Full Text

Ocal, Selin, Andrew J. Muir, and Susanna Naggie. “Hepatitis C Behind and Beyond Bars: Targeting the US Prison Population and Changing North Carolina Prisoner Health Policy.” N C Med J 80, no. 6 (November 2019): 352–55. https://doi.org/10.18043/ncm.80.6.352.

PMID
31685570
Full Text

Pages